Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 33 (CCDC33) is a protein encoded by the CCDC33 gene and contains several coiled-coil domains, a C2 domain, endoplasmic reticulum retention motifs, and peroxisomal targeting signals, directing the protein primarily to the peroxisome in male germ cells[1][2]. CCDC33 is predominantly expressed in testis, specifically in primary spermatocytes, suggesting a critical role in spermatogenesis[2][5]. It has also been identified as a cancer/testis antigen (CT antigen), indicating its potential relevance in certain cancers[2][5]. Genetic variations in CCDC33 have been correlated with increased susceptibility to invasive pneumococcal meningitis and altered expression observed in neurodegenerative contexts, such as Huntington’s disease[1]. The protein is multifunctional, implicated in both normal cellular processes and various disease contexts, but it is not currently known as a direct therapeutic drug target[1][4]. No drugs or specific clinical safety concerns associated with direct modulation of CCDC33 are reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 33 (CCDC33).